Besins Hlthcare Drug Patent Portfolio

Besins Hlthcare owns 1 orange book drug protected by 15 US patents Given below is the list of Besins Hlthcare's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8446138 Stability compensation circuit and DC-DC converter including the same 12 Oct, 2026
Active
US8466136 Testosterone gel and method of use 12 Oct, 2026
Active
US8466137 Testosterone gel and method of use 12 Oct, 2026
Active
US8466138 Testosterone gel and method of use 12 Oct, 2026
Active
US8486925 Testosterone gel and method of use 12 Oct, 2026
Active
US8729057 Testosterone gel and method of use 12 Oct, 2026
Active
US8741881 Testosterone gel and method of use 12 Oct, 2026
Active
US8754070 Testosterone gel and method of use 12 Oct, 2026
Active
US8759329 Testosterone gel and method of use 12 Oct, 2026
Active
US6503894 Pharmaceutical composition and method for treating hypogonadism 02 Mar, 2021 Expired
US9125816 Pharmaceutical composition and method for treating hypogonadism 02 Mar, 2021 Expired
US9132089 Pharmaceutical composition and method for treating hypogonadism 02 Mar, 2021 Expired
US6503894 Pharmaceutical composition and method for treating hypogonadism 30 Aug, 2020 Expired
US9125816 Pharmaceutical composition and method for treating hypogonadism 30 Aug, 2020 Expired
US9132089 Pharmaceutical composition and method for treating hypogonadism 30 Aug, 2020 Expired


Given below is the list of recent legal activities going on the following drug patents of Besins Hlthcare.

Activity Date Patent Number
Patent litigations
Expire Patent 23 Oct, 2023 US9132089 (Litigated)
Expire Patent 16 Oct, 2023 US9125816 (Litigated)
Maintenance Fee Reminder Mailed 08 May, 2023 US9132089 (Litigated)
Maintenance Fee Reminder Mailed 01 May, 2023 US9125816 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 11 Nov, 2021 US8741881 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 11 Nov, 2021 US8759329 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 11 Nov, 2021 US8754070 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 14 Oct, 2021 US8729057 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 18 Dec, 2020 US8486925
Payment of Maintenance Fee, 8th Year, Large Entity 28 Sep, 2020 US8466137
Payment of Maintenance Fee, 8th Year, Large Entity 28 Sep, 2020 US8466138
Payment of Maintenance Fee, 8th Year, Large Entity 28 Sep, 2020 US8466136
Payment of Maintenance Fee, 8th Year, Large Entity 25 Sep, 2020 US8446138
Payment of Maintenance Fee, 4th Year, Large Entity 14 Feb, 2019 US9125816 (Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 14 Feb, 2019 US9132089 (Litigated)


Besins Hlthcare Drug Patents' Oppositions Filed in EPO

Besins Hlthcare drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Aug 21, 2013, by Oser, Andreas. This opposition was filed on patent number EP06836341A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP06836341A Aug, 2013 Oser, Andreas Opposition rejected


Besins Hlthcare's Family Patents

Besins Hlthcare drugs have patent protection in a total of 29 countries. It's US patent count contributes only to 26.9% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Besins Hlthcare Drug List

Given below is the complete list of Besins Hlthcare's drugs and the patents protecting them.


1. Androgel

Androgel is protected by 16 patents, out of which 7 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8446138 Stability compensation circuit and DC-DC converter including the same 12 Oct, 2026
(2 years from now)
Active
US8466136 Testosterone gel and method of use 12 Oct, 2026
(2 years from now)
Active
US8466137 Testosterone gel and method of use 12 Oct, 2026
(2 years from now)
Active
US8466138 Testosterone gel and method of use 12 Oct, 2026
(2 years from now)
Active
US8486925 Testosterone gel and method of use 12 Oct, 2026
(2 years from now)
Active
US8729057 Testosterone gel and method of use 12 Oct, 2026
(2 years from now)
Active
US8741881 Testosterone gel and method of use 12 Oct, 2026
(2 years from now)
Active
US8754070 Testosterone gel and method of use 12 Oct, 2026
(2 years from now)
Active
US8759329 Testosterone gel and method of use 12 Oct, 2026
(2 years from now)
Active
US6503894
(Pediatric)
Pharmaceutical composition and method for treating hypogonadism 02 Mar, 2021
(3 years ago)
Expired
US9125816
(Pediatric)
Pharmaceutical composition and method for treating hypogonadism 02 Mar, 2021
(3 years ago)
Expired
US9132089
(Pediatric)
Pharmaceutical composition and method for treating hypogonadism 02 Mar, 2021
(3 years ago)
Expired
US6503894
(Pediatric)
Pharmaceutical composition and method for treating hypogonadism 01 Mar, 2021
(3 years ago)
Expired
US6503894 Pharmaceutical composition and method for treating hypogonadism 30 Aug, 2020
(4 years ago)
Expired
US9125816 Pharmaceutical composition and method for treating hypogonadism 30 Aug, 2020
(4 years ago)
Expired
US9132089 Pharmaceutical composition and method for treating hypogonadism 30 Aug, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Androgel's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List